BRCA1 mutation higher in Ashkenazi women:
This article was originally published in Clinica
Executive Summary
The BRCA1 gene mutation 185delAG may account for 16% of breast cancers and 39% of ovarian cancers diagnosed in Ashkenazi women under the age of 50, new research suggests (Nature Genetics, vol 11. The deletion carrier rate was found to be at least three times higher in Ashkenazi women than in the general US population.